| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.067 | 0.01 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |